Test Price
2,800 AED✅ Home Collection Available
GALNS Gene Mucopolysaccharidosis Type IVA (Morquio A) Genetic Test – 2800 AED
Executive Summary & Core Metrics
Core Metrics
- Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 9001:2015 accredited processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP mobile phlebotomy and temperature-controlled cold-chain home collection available daily from 8 AM to 11 PM across all UAE emirates.
- Clinical Guidance: Telephonic post-test clinical guidance in result interpretation provided by board-certified specialists.
- Regulatory Compliance: Fully compliant with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Insurance: Direct billing verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The GALNS Gene NGS Test sequences the entire coding region of the GALNS gene to detect pathogenic variants causing Mucopolysaccharidosis Type IVA (Morquio A Syndrome), a rare inherited metabolic disorder. This next‑generation sequencing analysis delivers a definitive molecular diagnosis for affected individuals, supports carrier screening, and informs family planning decisions.
| Feature | Our Test | Standard Genetic Panel |
|---|---|---|
| Precision | 99.9% Diagnostic Sensitivity | ~95% (limited to targeted regions) |
| Methodology | Next-Generation Sequencing (NGS) with full gene coverage & CNV analysis | Sanger sequencing of selected exons |
| Turnaround Time | 3 to 4 Weeks | 6 to 8 Weeks (often outsourced) |
| Sample Options | Blood, FTA Card, Extracted DNA | Blood only |
| Regulatory Adherence | ISO 9001:2015, UAE PDPL, Federal Law No. 2 of 2019 | Limited or unspecified |
Pre-Test Requirements
A detailed clinical history of the patient is mandatory. A genetic counselling session must be undertaken to draw a pedigree chart identifying family members affected by Mucopolysaccharidosis type IVA, ensuring accurate variant interpretation and risk stratification.
Physician Insight & Safety Protocols
“As a consultant medical geneticist, I emphasize that a positive GALNS mutation requires correlation with biochemical and enzymatic activity. This test is a powerful diagnostic aid, but clinical expertise and family history must guide final interpretation and management. All procedures adhere strictly to Federal Decree-Law No. 4 of 2016 on Medical Liability and patient consent standards.” – Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Safety Advisory
⚠ Medication Warning
Do not discontinue any prescribed medication without consulting your doctor. Genetic testing does not replace ongoing medical management or emergency care.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Patients who have undergone allogeneic bone marrow transplantation within the last 3 months (donor DNA interference).
- Exclusion: Inadequate sample volume or improper sample collection (e.g., FTA card not fully saturated).
- Red Flag: If your child experiences acute respiratory distress or severe skeletal pain, seek immediate emergency care, irrespective of test results.
- Red Flag: A negative variant report does not rule out the condition if clinical suspicion remains high; further enzymatic or biochemical testing is advised.
Patient FAQ & Clinical Guidance
1. What does the GALNS gene test detect, and why is it important for Morquio A syndrome?
The GALNS Genetic Test identifies pathogenic mutations in the GALNS gene with 99.9% sensitivity, providing a definitive molecular diagnosis of Mucopolysaccharidosis Type IVA and guiding enzyme replacement therapy, surgical planning, and family risk assessment.
2. How is the sample collected, and do you offer home collection in the UAE?
Our VIP mobile phlebotomy service provides hospital‑grade home collection for blood, FTA card, or pre‑extracted DNA across Dubai, Abu Dhabi, and all emirates with cold‑chain logistics, ensuring sample stability and convenience for families. Service is available daily from 8 AM to 11 PM.
3. Is the test covered by insurance, and how can I verify my plan?
We offer direct billing verification via WhatsApp at +971 54 548 8731; our team will check your insurance policy’s coverage for genetic testing under UAE healthcare networks within one business hour.
4. How long does it take to receive results?
The turnaround time is 3 to 4 weeks from sample receipt. You will be notified via phone and email as soon as the report is ready.
UAE Regulatory & Data Privacy Adherence
This test is performed in full compliance with UAE personal data protection laws. All patient genomic data is handled under Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. No genetic information is shared with third parties without explicit written consent. Retail archives are encrypted and access is restricted to authorized medical personnel only.
Clinical & Logistical Metadata
| Test Name | GALNS Gene Mucopolysaccharidosis Type IVA Genetic Test (NGS) |
| Price (AED) | 2,800 |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (EDTA), FTA Card, or Extracted DNA |
| Methodology Used | Next-Generation Sequencing (NGS) – Full gene coverage with CNV analysis |
| ICD-10-CM Code | E76.2 (Morquio mucopolysaccharidosis) |
| LOINC Code | 83365-7 (GALNS gene analysis) |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians